Liberty Global Ltd. (LBTYK) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 3.43%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 3.43% | Share-based compensation / revenue. Period ending 2026-06-30. $167.60M ÷ $4.88B × 100 ≈ 3.43% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 4.88B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 167.60M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -86.80M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $4.88B | $167.60M | $-86.80M | (m) | (m) | 3.43% | (m) | (m) |
| 2026-03-31 | (m) | $4.98B | $173.10M | $-60.20M | (m) | (m) | 3.47% | (m) | (m) |
| 2025-12-31 | (m) | $4.88B | $169.40M | $-23.30M | (m) | (m) | 3.47% | (m) | (m) |
| 2025-09-30 | (m) | $4.77B | $168.30M | $34.10M | (m) | (m) | 3.53% | (m) | (m) |
| 2025-06-30 | (m) | $4.63B | $168.70M | $75.50M | (m) | (m) | 3.64% | (m) | (m) |
| 2025-03-31 | (m) | $4.42B | $162.70M | $12.90M | (m) | (m) | 3.68% | (m) | (m) |
| 2024-12-31 | (m) | $4.34B | $168.30M | $-60.10M | (m) | (m) | 3.88% | (m) | (m) |
| 2024-09-30 | (m) | $7.67B | $203.60M | $-62.30M | (m) | (m) | 2.65% | (m) | (m) |
| 2024-06-30 | (m) | $7.59B | $205.50M | $-191.00M | (m) | (m) | 2.71% | (m) | (m) |
| 2024-03-31 | (m) | $7.57B | $231.80M | $-259.30M | $960.50M | (m) | 3.06% | -0.27× | Reported |
| 2023-12-31 | (m) | $7.49B | $231.00M | $-244.50M | $907.90M | (m) | 3.08% | -0.27× | Reported |
| 2023-09-30 | (m) | $7.41B | $223.10M | $-84.60M | $828.50M | (m) | 3.01% | -0.10× | Reported |
| 2023-06-30 | (m) | $7.30B | $211.00M | $51.70M | $736.80M | (m) | 2.89% | 0.07× | Reported |
| 2023-03-31 | (m) | $7.21B | $184.50M | $125.40M | $656.00M | (m) | 2.56% | 0.19× | Reported |
| 2022-12-31 | (m) | $7.20B | $192.10M | $146.80M | $589.30M | (m) | 2.67% | 0.25× | Reported |
| 2022-09-30 | (m) | $7.27B | $230.90M | $273.10M | $550.80M | (m) | 3.17% | 0.50× | Reported |
| 2022-06-30 | (m) | $7.43B | $245.60M | $265.20M | $542.00M | (m) | 3.31% | 0.49× | Reported |
| 2022-03-31 | (m) | $8.66B | $296.10M | $777.90M | $681.60M | (m) | 3.42% | 1.14× | Reported |
| 2021-12-31 | (m) | $10.31B | $308.10M | $1.32B | $882.10M | (m) | 2.99% | 1.50× | Reported |
| 2021-09-30 | (m) | $12.14B | $325.20M | $1.95B | $1.06B | (m) | 2.68% | 1.84× | Reported |
| 2021-06-30 | (m) | $13.10B | $372.20M | $2.50B | $1.20B | (m) | 2.84% | 2.08× | Reported |
| 2021-03-31 | (m) | $12.72B | $356.20M | $2.46B | $1.21B | (m) | 2.80% | 2.03× | Reported |
| 2020-12-31 | (m) | $11.98B | $348.00M | $2.12B | $1.19B | (m) | 2.90% | 1.78× | Reported |
| 2020-09-30 | (m) | $11.54B | $320.90M | $1.75B | $1.19B | (m) | 2.78% | 1.47× | Reported |
| 2020-06-30 | (m) | $11.42B | $290.50M | $1.30B | $1.25B | (m) | 2.54% | 1.04× | Reported |
| 2020-03-31 | (m) | $11.55B | $293.70M | $920.60M | $1.33B | (m) | 2.54% | 0.69× | Reported |
| 2019-12-31 | (m) | $11.54B | $305.80M | $745.50M | $1.39B | (m) | 2.65% | 0.54× | Reported |
| 2019-09-30 | (m) | $11.51B | $303.30M | $715.20M | $1.43B | (m) | 2.64% | 0.50× | Reported |
| 2019-06-30 | (m) | (m) | $272.10M | $711.60M | $1.45B | (m) | (m) | 0.49× | Reported |
| 2019-03-31 | (m) | (m) | $230.60M | $827.00M | $1.47B | (m) | (m) | 0.56× | Reported |
| 2018-12-31 | (m) | $11.96B | $206.00M | $839.10M | $1.48B | (m) | 1.72% | 0.57× | Reported |
| 2018-09-30 | (m) | (m) | $203.10M | $1.89B | $1.96B | (m) | (m) | 0.97× | Reported |
| 2018-06-30 | (m) | (m) | $181.80M | $1.91B | $1.96B | (m) | (m) | 0.97× | Reported |
| 2018-03-31 | (m) | $15.69B | $186.30M | $2.01B | $1.92B | (m) | 1.19% | 1.05× | Reported |
| 2017-12-31 | (m) | $15.05B | $173.90M | $1.95B | $1.89B | (m) | 1.16% | 1.03× | Reported |
| 2017-09-30 | (m) | $18.94B | $212.40M | $2.37B | $2.39B | (m) | 1.12% | 0.99× | Reported |
| 2017-06-30 | (m) | $19.36B | $248.70M | $2.94B | $2.47B | (m) | 1.28% | 1.19× | Reported |
| 2017-03-31 | (m) | $19.85B | $266.90M | $2.78B | $2.57B | (m) | 1.34% | 1.08× | Reported |
| 2016-12-31 | (m) | $20.01B | $296.90M | $2.80B | $2.64B | (m) | 1.48% | 1.06× | Reported |
| 2016-09-30 | (m) | $19.47B | $271.60M | $2.60B | $2.55B | (m) | 1.40% | 1.02× | Reported |
| 2016-06-30 | (m) | $18.86B | $333.80M | $2.24B | $2.50B | (m) | 1.77% | 0.90× | Reported |
| 2016-03-31 | (m) | $18.35B | $315.80M | $2.38B | $2.44B | (m) | 1.72% | 0.97× | Reported |
| 2015-12-31 | (m) | $18.28B | $318.20M | $2.35B | $2.44B | (m) | 1.74% | 0.96× | Reported |
| 2015-09-30 | (m) | $18.30B | $327.60M | $2.00B | $2.47B | (m) | 1.79% | 0.81× | Reported |
| 2015-06-30 | (m) | $18.20B | $275.70M | $2.16B | $2.47B | (m) | 1.52% | 0.88× | Reported |
| 2015-03-31 | (m) | $18.23B | $273.50M | $2.20B | $2.51B | (m) | 1.50% | 0.88× | Reported |
| 2014-12-31 | (m) | $18.25B | $257.20M | $2.23B | $2.54B | (m) | 1.41% | 0.88× | Reported |
| 2014-09-30 | (m) | $18.10B | $265.40M | $2.47B | $2.56B | (m) | 1.47% | 0.97× | Reported |
| 2014-06-30 | (m) | $17.88B | $290.50M | $2.29B | $2.57B | (m) | 1.62% | 0.89× | Reported |
| 2014-03-31 | (m) | $16.34B | $329.50M | $2.07B | $2.47B | (m) | 2.02% | 0.84× | Reported |
| 2013-12-31 | (m) | $14.47B | $300.70M | $2.01B | $2.29B | (m) | 2.08% | 0.88× | Reported |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $10.15B | (m) | $2.02B | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $9.93B | $110.10M | $1.98B | $1.67B | (m) | 1.11% | 1.18× | Reported |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $9.12B | $129.40M | $1.82B | $1.45B | (m) | 1.42% | 1.25× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.